DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
DEBIO-1347 is an investigational drug.
There have been 20 clinical trials for DEBIO-1347. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2015.
The most common disease conditions in clinical trials are Bacterial Infections, Hepatitis, Chronic, and Hepatitis C, Chronic. The leading clinical trial sponsors are Debiopharm International SA, Centre Leon Berard, and Merck Sharp & Dohme Corp.
Recent Clinical Trials for DEBIO-1347
|Study of Oral Debio 0123 in Combination With Carboplatin in Participants With Advanced Solid Tumors||Debiopharm International SA||Phase 1|
|Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143||Debiopharm International SA||Phase 1/Phase 2|
|Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma||Debiopharm International SA||Phase 1|